Hypoxia induces gefitinib resistance in non‐small‐cell lung cancer with both mutant and wild‐type epidermal growth factor receptors

Somatic mutations in the epidermal growth factor receptor (EGFR) gene, such as exon 19 deletion mutations, are important factors in determining therapeutic responses to gefitinib in non‐small‐cell lung cancer (NSCLC). However, some patients have activating mutations in EGFR and show poor responses t...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Cancer Sci
Huvudupphovsmän: Minakata, Kunihiko, Takahashi, Fumiyuki, Nara, Takeshi, Hashimoto, Muneaki, Tajima, Ken, Murakami, Akiko, Nurwidya, Fariz, Yae, Suzu, Koizumi, Fumiaki, Moriyama, Hiroyuki, Seyama, Kuniaki, Nishio, Kazuto, Takahashi, Kazuhisa
Materialtyp: Artigo
Språk:Inglês
Publicerad: John Wiley and Sons Inc. 2012
Ämnen:
Original Articles
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7659171/
https://ncbi.nlm.nih.gov/pubmed/22863020
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1349-7006.2012.02408.x
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk